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Wedescribe apatientwithfeverandborreliosisintheNorthwestern WashingtonState,USA.Thepatientexhibited aclassicJarisch-
Herxheimer reaction of tachycardia, hypotension, and thrombocytopenia followingantimicrobial therapy, and she also developed
an elevated serum cardiac troponin during therapy.
1.Introduction
Tick-borne relapsing fever is caused by many diﬀerent Bor-
relia species. One soft-bodied tick, Ornithodoros hermsii acts
as a vector for the organism B. hermsii [1]. These ticks are
c o m m o ni nt h eW e s t e r nU n i t e dS t a t e sa n dS o u t h e r nB r i t i s h
Columbia [2]. The spirochete-infected ticks feed for short
periodsduringthenightandthenfalloﬀ.Duringtheensuing
spirochetemia, a sudden onset of febrile illness occurs and
is characterized by rigors, headache, myalgia, vomiting,
abdominal pain, and cough [3, 4]. Deﬁnitive diagnosis can
be made by the microscopic identiﬁcation of loosely coiled
spirochetes in a peripheral blood smear. We report a case
of borreliosis in Whatcom County, Wash, USA complicated
by the Jarisch-Herxheimer reaction (J-HR) and increased
cardiac troponin.
2.CaseReport
A 75-year-old woman was seen at a local hospital with a
chief complaintof febrile illness and myalgia. She had a heart
rate of 145bpm and a systolic blood pressure of 140mmHg
(Figure 1). Past medical history was unremarkable. She
reported no known drug allergies and no current medica-
tions. There was no recent travel history. She reported no
known tick bites. No unusual dietary exposure was noted.
Within 30 minutes of admission, she complained of muscle
cramps and had clammy skin and diarrhea. She appeared
dehydrated and was started on saline intravenously for clin-
ical dehydration and diagnosed with a likely viral illness and
possible sepsis. A urinalysis revealed 3+ leukocyte esterase,
2+ protein, 95 white blood cells/hpf, and many bacteria.
A comprehensive metabolic panel showed elevated renal
(urea nitrogen = 10.5mmol/L, creatinine = 114.9µmol/L)
and liver enzymes (AST = 114U/L, ALT = 163U/L), high
glucose (8.56mmol/L), and normal electrolytes. The patient
was nonreactive for Hepatitis A IgM, Hepatitis B core IgM
and surface IgG antibodies, and Hepatitis B surface antigen
and HIV. A baseline troponin I was 0.03µg/L. A complete
bloodcountshowed whitebloodcells(WBC)of10.0 ×109/L
and a hematocrit of 0.404. She was thrombocytopenic with
a platelet count of 92 × 109/L. Microscopic examination
of the peripheral blood smear revealed numerous loosely-
coiled spirochetes consistent with Borrelia sp. infection
(Figure 2). A working diagnosis of tick-borne relapsing fever
(TBRF) was made. The patient was started on pantoprazole,
levoﬂoxin, and acetaminophen. Within 4 hours of antibiotic
administration there was a clinical worsening of symptoms
complicated by Jarisch-Herxheimer reaction (J-HR). The
patient’s temperature, blood pressure, and platelet count
decreased rapidly (Figure 1). A urine culture was positive for
E. coli, and antimicrobial therapy was changed to ertapenem2 Case Reports in Infectious Diseases
Figure 1: Loosely coiled Borrelia sp. in a thin peripheral blood
smear stained with Wright-Giemsa stain and visualized under oil
immersion(×500).
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Figure 2: Time course of Jarisch-Herxheimer reaction (J-HR) in
relapsing fever. Antimicrobial therapy was started at time 0. Symp-
toms of rapid decrease in temperature, hypotension, and throm-
bocytopenia correlated with peripheral blood spirochete clearance
(pattern). Sepsis resulted in elevated serum cardiac troponin
without acute coronary syndrome at 36 and 48 hours compared to
time 0.
and ciproﬂoxin based on susceptibility testing results. At 12
hours, spirochetes were no longer visible on the peripheral,
and the patient became afebrile. At the time of 36 hours of
admission, the patient complained of chest and low-back
pain. A repeat troponin was 0.28µg/L. She was started on
metoprolol and transferred to the cardiovascular unit for
observation. At the time of 48hrs, a repeat troponin was
0.96µg/L. During the next 12 hours of supportive treatment,
the thrombocytopenia improved (112 × 109/L), and angina
and febrile illness resolved. She was discharged with instruc-
tions to follow up with her primary care provider within
10 days. Fourteen days after onset of the illness, the patient’s
platelet count had normalized to 235 × 109/L. Serological
testing for Borrelia sp. wasperformed onspecimens collected
on day 1 (acute) and on day 120 (convalescent). The acute
specimen was negative whereas the convalescent specimen
was positive for antibodies to B. hermsi.
3.Discussion
The J-HR is a well-known complication of antimicrobial
therapytoborreliosis.Similartothiscasestudy,Websteretal.
(2002) outlined a J-HR following administration of ﬂuo-
roquinolones in TBRF [5]. Other studies have shown that
cytokines, namely, tumor necrosis factor, interleukin-8, and
-16, appear in the circulation transiently and correlate with
symptom severity in TBRF [6]. Antibodies against inﬂam-
matory cytokines have been shown to decrease the J-HR [7].
Sepsis that results from the presence of infectious organisms
or their toxins in the blood is frequently associated with
changes in these inﬂammatory mediators [8]. Furthermore,
elevations in cardiac troponin in patients with sepsis are
common [9]. Notably, this is one of the ﬁrst published
reports of transient increases in cardiac troponin in TBRF.
Thepotentialcausesoftroponinreleaseduringsepsisinclude
decreased cardiac membrane integrity, bacterial endotoxins,
and thrombotic dysfunction and are unlikely due to ﬂow-
limiting etiologies [10]. While the therapy of TBRF is well
established and the response to antimicrobial agents is
predictably good, complications such as sepsis, the J-HR and
elevated cardiac troponin may increase mortality rates.
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